|

Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Sun Yat-sen University1

Indications

  • Liver Disease1
  • Beyond Milan Criteria1
  • Liver Cancer1
  • Hepatocellular Carcinoma1
  • Cancer1

Other1 trial

Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.